HARVARD BIOSCIENCE, INC. (HBIO) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 36.68M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 76.29M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $0.00 | $36.68M | (m) | (m) | $76.29M | (m) |
| 2026-03-31 | (m) | (m) | $0.00 | $36.21M | (m) | (m) | $77.94M | (m) |
| 2025-12-31 | (m) | (m) | $0.00 | $35.87M | (m) | (m) | $80.07M | (m) |
| 2024-12-31 | (m) | (m) | $37.35M | $0.00 | (m) | (m) | $126.64M | (m) |
| 2024-09-30 | (m) | (m) | $4.00M | $34.25M | (m) | (m) | $131.24M | (m) |
| 2024-06-30 | (m) | (m) | $4.00M | $31.96M | (m) | (m) | $128.91M | (m) |
| 2024-03-31 | (m) | (m) | $4.00M | $31.89M | (m) | (m) | $133.16M | (m) |
| 2023-12-31 | (m) | (m) | $6.14M | $30.70M | (m) | (m) | $137.37M | (m) |
| 2023-09-30 | (m) | (m) | $3.75M | $35.27M | (m) | (m) | $139.74M | (m) |
| 2023-06-30 | (m) | (m) | $3.50M | $38.20M | (m) | (m) | $142.90M | (m) |
| 2023-03-31 | (m) | (m) | $3.25M | $41.08M | (m) | (m) | $145.58M | (m) |
| 2022-12-31 | (m) | (m) | $4.09M | $43.01M | (m) | (m) | $145.36M | (m) |
| 2022-09-30 | (m) | (m) | $3.00M | $46.53M | (m) | (m) | $147.01M | (m) |
| 2022-06-30 | (m) | (m) | $3.00M | $45.76M | (m) | (m) | $155.27M | (m) |
| 2022-03-31 | (m) | (m) | $3.00M | $46.24M | (m) | (m) | $158.04M | (m) |
| 2021-12-31 | (m) | (m) | $3.52M | $45.09M | (m) | (m) | $162.34M | (m) |
| 2021-09-30 | (m) | (m) | $2.75M | $42.74M | (m) | (m) | $153.87M | (m) |
| 2021-06-30 | (m) | (m) | $2.50M | $40.92M | (m) | (m) | $153.97M | (m) |
| 2021-03-31 | (m) | (m) | $2.25M | $41.60M | (m) | (m) | $151.25M | (m) |
| 2020-12-31 | (m) | (m) | $2.00M | $46.29M | (m) | (m) | $156.25M | (m) |
| 2020-09-30 | (m) | (m) | $3.20M | $40.67M | (m) | (m) | $149.61M | (m) |
| 2020-06-30 | (m) | (m) | $3.20M | $40.92M | (m) | (m) | $150.69M | (m) |
| 2020-03-31 | (m) | (m) | $3.20M | $46.28M | (m) | (m) | $156.26M | (m) |
| 2019-12-31 | (m) | (m) | $3.20M | $46.92M | (m) | (m) | $164.87M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $51.71M | (m) | (m) | $162.78M | (m) |
| 2019-06-30 | (m) | (m) | (m) | $52.41M | (m) | (m) | $166.24M | (m) |
| 2019-03-31 | (m) | (m) | (m) | $54.13M | (m) | (m) | $171.34M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $58.80M | (m) | (m) | $168.61M | (m) |
| 2018-09-30 | (m) | (m) | (m) | $59.25M | (m) | (m) | $165.04M | (m) |
| 2018-06-30 | (m) | (m) | (m) | $59.83M | (m) | (m) | $165.05M | (m) |
| 2018-03-31 | (m) | (m) | (m) | $61.57M | (m) | (m) | $170.95M | (m) |
| 2017-12-31 | (m) | (m) | (m) | $8.98M | (m) | (m) | $109.35M | (m) |
| 2017-09-30 | (m) | (m) | (m) | $9.67M | (m) | (m) | $110.68M | (m) |
| 2017-06-30 | (m) | (m) | (m) | $10.42M | (m) | (m) | $108.86M | (m) |
| 2017-03-31 | (m) | (m) | (m) | $10.93M | (m) | (m) | $107.40M | (m) |
| 2016-12-31 | (m) | (m) | (m) | $11.37M | (m) | (m) | $107.77M | (m) |
| 2016-09-30 | (m) | (m) | (m) | $12.67M | (m) | (m) | $112.18M | (m) |
| 2016-06-30 | (m) | (m) | (m) | $13.77M | (m) | (m) | $114.08M | (m) |
| 2016-03-31 | (m) | (m) | (m) | $14.77M | (m) | (m) | $117.88M | (m) |
| 2015-12-31 | (m) | (m) | (m) | $16.45M | (m) | (m) | $120.22M | (m) |
| 2015-09-30 | (m) | (m) | (m) | $15.15M | (m) | (m) | $133.56M | (m) |
| 2015-06-30 | (m) | (m) | (m) | $15.65M | (m) | (m) | $138.58M | (m) |
| 2015-03-31 | (m) | (m) | (m) | $16.90M | (m) | (m) | $134.12M | (m) |
| 2014-12-31 | (m) | (m) | (m) | $16.45M | (m) | (m) | $135.92M | (m) |
| 2014-09-30 | (m) | (m) | (m) | $18.20M | (m) | (m) | $136.13M | (m) |
| 2014-06-30 | (m) | (m) | (m) | $17.25M | (m) | (m) | $137.71M | (m) |
| 2014-03-31 | (m) | (m) | (m) | $18.50M | (m) | (m) | $135.29M | (m) |
| 2013-12-31 | (m) | (m) | (m) | $19.75M | (m) | (m) | $135.46M | (m) |
| 2013-09-30 | (m) | (m) | (m) | $20.50M | (m) | (m) | $148.34M | (m) |
| 2013-06-30 | (m) | (m) | (m) | $21.25M | (m) | (m) | $146.05M | (m) |
| 2013-03-31 | (m) | (m) | (m) | $12.00M | (m) | (m) | $135.44M | (m) |
| 2012-12-31 | (m) | (m) | (m) | $12.95M | (m) | (m) | $133.48M | (m) |
| 2012-09-30 | (m) | (m) | (m) | $15.30M | (m) | (m) | $130.58M | (m) |
| 2012-06-30 | (m) | (m) | (m) | $16.10M | (m) | (m) | $129.53M | (m) |
| 2012-03-31 | (m) | (m) | (m) | $16.80M | (m) | (m) | $131.51M | (m) |
| 2011-12-31 | (m) | (m) | (m) | $16.30M | (m) | (m) | $126.63M | (m) |
| 2011-09-30 | (m) | (m) | (m) | $16.30M | (m) | (m) | $126.97M | (m) |
| 2011-06-30 | (m) | (m) | (m) | $17.11M | (m) | (m) | $129.01M | (m) |
| 2010-12-31 | (m) | (m) | (m) | $18.01M | (m) | (m) | $124.80M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |